Similar articles

• Methods for the therapeutic applications of immobilized enzymes.

  Chang TM. Chang TM. Methods Enzymol. 1976;44:676-98. Methods Enzymol. 1976. PMID: 1021699 No abstract available.
• [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].

  Zhou J, Jin H, Li Y, Jiang T. Zhou J, et al. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2000 Sep;17(3):343-5. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2000. PMID: 11285852 Review. Chinese.
• Antitumor enzyme: polyethylene glycol-modified asparaginase.

  Wada H, Imamura I, Sako M, Katagiri S, Tarui S, Nishimura H, Inada Y. Wada H, et al. Ann N Y Acad Sci. 1990;613:95-108. doi: 10.1111/j.1749-6632.1990.tb18151.x. Ann N Y Acad Sci. 1990. PMID: 2076022 Review. No abstract available.
• [High molecular weight L-asparaginase derivatives based on a water-soluble carboxymethyl cellulose: biological properties].

  Karsakevich AS, Kinstler OB, Dauvarte AZh, Vina IA. Karsakevich AS, et al. Vopr Med Khim. 1988 May-Jun;34(3):107-10. Vopr Med Khim. 1988. PMID: 3420797 Russian.
• Enzyme therapy of cancer, future studies.

  Holcenberg JS. Holcenberg JS. Cancer Treat Rep. 1981;65 Suppl 4:61-5. Cancer Treat Rep. 1981. PMID: 7346158